ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

SEEL Seelos Therapeutics Inc

0,34
0,01 (3,03%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Seelos Therapeutics Inc SEEL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,01 3,03% 0,34 01:39:22
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,342 0,33 0,355 0,3393 0,33
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.3.202423:32EDGAR2Form S-1/A - General form for registration of securities..
06.3.202422:50EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01.3.202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:50EDGAR2Form D - Notice of Exempt Offering of Securities
06.2.202423:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02.2.202412:04EDGAR2Form S-1 - General form for registration of securities under..
30.1.202422:01EDGAR2Form 8-K - Current report
30.1.202412:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22.1.202414:05EDGAR2Form 8-K - Current report
18.1.202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:16EDGAR2Form 8-K - Current report
09.1.202403:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202414:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22.12.202322:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22.12.202314:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20.12.202322:59EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20.12.202322:54EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18.12.202322:54EDGAR2Form S-3 - Registration statement under Securities Act of..
15.12.202322:06EDGAR2Form DEF 14A - Other definitive proxy statements
04.12.202322:05EDGAR2Form PRE 14A - Other preliminary proxy statements
01.12.202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202322:08EDGAR2Form 8-K - Current report
30.11.202322:59EDGAR2Form 8-K - Current report
30.11.202322:58EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28.11.202322:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28.11.202322:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28.11.202315:00EDGAR2Form 8-K - Current report
24.11.202318:07EDGAR2Form 8-K - Current report
24.11.202317:10EDGAR2Form 8-K - Current report
03.11.202321:15EDGAR2Form 8-K - Current report
02.10.202312:03EDGAR2Form 8-K - Current report
29.9.202322:56EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25.9.202322:06EDGAR2Form 8-K - Current report
25.9.202312:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20.9.202313:00EDGAR2Form 8-K - Current report
15.9.202322:01EDGAR2Form S-3 - Registration statement under Securities Act of..
14.9.202315:00EDGAR2Form 8-K - Current report
01.9.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29.6.202315:00EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock